The next era of health advertising will be defined by infrastructure, not workarounds. Privacy-safe audiences activated before diagnosis. Premium supply connected to closed-loop measurement. Intelligence that compounds across the patient journey instead of fragmenting across it.
This is a different starting point than the one most health advertisers are working from today. Claims-based targeting was built to identify patients after diagnosis. Walled gardens traded transparency for scale. Measurement was retrofitted onto journeys it was never designed for. The pieces worked. They just weren’t built to work together.
What’s changing isn’t a single tool. It’s the foundation.
The Infrastructure Built for Yesterday’s Playbook
Health advertising’s current toolkit was built for a different problem. Claims-based targeting was designed when the goal was identifying patients after diagnosis — a retrospective view of who had already acted. Walled gardens were built when scale was the scarce resource, before transparency became the harder thing to find. Measurement was layered onto patient journeys after the fact, never designed for the multi-week, multi-touchpoint reality of how health decisions actually get made.
Each of those choices made sense in its moment. None of them were built for where health advertising is going.
The market is making that clear in real time. Meta has tightened enforcement of health-related conversion tracking, limiting lower-funnel optimization. LinkedIn — the go-to channel for reaching healthcare providers — has begun blocking its tracking tag on healthcare domains, shrinking retargeting pools and eliminating cookie-based audiences. These aren’t isolated policy changes. They’re the predictable result of building patient-reach strategies on infrastructure that was never designed for health’s privacy reality.
The question isn’t how to patch what’s contracting. It’s what health advertising looks like when it’s built on a foundation designed for where the category is going.
What Changes When the Foundation Changes
Infillion Health starts from a different premise: that privacy-safe audiences don’t have to be smaller, less precise, or less actionable. Built without dependence on legacy tracking infrastructure, they can actually outperform it.
The foundation is over 4 billion U.S. health records (medical claims, pharmacy claims, EHR data, and federal datasets) predictively modeled to identify likely patients before diagnosis. What’s activated is a privacy-safe audience, not a health record.
This is a performance advantage first, and a compliance win on top of it. Because the intelligence is built on what’s likely to happen next, not just who’s already been diagnosed, you’re reaching patients earlier in the care journey, when education has the greatest influence on outcomes and when brand choice is still being formed.
Earlier in the Journey. Across Every Use Case.
For Rx advertisers, that means audiences like adults likely to receive a diagnosis in the next three to six months, or patients showing early signals of therapy initiation. Not lookalikes built from probabilistic proxies — segments verified against claims data, with measurable condition prevalence and a deployment timeline measured in days.
For OTC advertisers, it means reaching consumers before they’re actively shopping, when brand preference is still forming, rather than competing for the same in-market buyer that everyone else is chasing. The Infillion Catalina integration extends this purchase-based audience intelligence across 70 major retail banners and 400 million U.S. households, tying media exposure directly to retail conversion.
Across both, 5 million zero-party survey responses and 105 million engaged CTV viewers surface consumers who are actively researching symptoms, weighing treatment options, or managing conditions they’ve self-declared, thereby adding live signals to the predictive foundation.
The result is a closed loop: smarter data into premium inventory, into interactive creative, into measurement that proves what actually happened — script lift, diagnosis lift, retail sales lift — verified through privacy-safe methodologies and trusted third-party partners.
Orchestrated Together, the Outcomes Compound
Infillion Health’s difference is architectural. Smarter audience intelligence, interactive creative, premium supply, and closed-loop measurement were built together on one composable platform. When these components are orchestrated as a system, performance compounds across the entire patient journey, from first awareness to proven outcome.
The Path Forward
The data infrastructure health advertisers have relied on is contracting. Building better workarounds on a weakening foundation isn’t a strategy. The teams that will outperform in this environment are the ones that stop patching and start building on infrastructure designed for where health advertising is going, not where it’s been.
Infillion Health was designed for that moment. Privacy-safe intelligence, premium supply, and closed-loop measurement, composed as a system instead of stitched together as a stack.
The path forward for health advertisers isn’t more data. It’s a smarter infrastructure.
See what health advertising looks like on infrastructure designed for it. Explore Infillion Health.
